A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/2006
11/23/2006	WO2006125134A1 Peptides whose uptake by cells is controllable
11/23/2006	US20060264603 treating edema with Kallikrein inhibitor; bovine pancreatic trypsin inhibitor mutants; possibly ecallantide
11/23/2006	US20060263303 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/23/2006	US20060263295 Chelators for radioactively labeled conjugates comprising a stabilizing sidechain
11/23/2006	US20060263294 Tumor targeting agents and uses thereof
11/23/2006	US20060263293 Click chemistry method for synthesizing molecular imaging probes
11/23/2006	CA2611468A1 Peptides whose uptake by cells is controllable
11/22/2006	EP1724349A1 TIE Ligand Homologues
11/22/2006	EP1723161A1 Radiolabeled compounds and compositions, their precursors and methods for their production
11/22/2006	EP1723154A2 Isotopically-enriched boranes and methods of preparing them
11/22/2006	EP1723139A1 Cell targeting conjugates
11/22/2006	EP1722827A2 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
11/22/2006	EP1722826A2 Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses
11/22/2006	EP1722818A2 Photoreactive compound specifically binding to calcium binding proteins
11/22/2006	EP1424083B1 Diagnostic agent for pancreatic exocrine function
11/22/2006	EP1361899B1 Silicon implants comprising a radionucleotide for use in brachytherapy
11/22/2006	EP0970104B1 Steroid sulfamates, method for the production and use thereof
11/22/2006	CN1867363A Mechanism-based targeted pancreatic beta cell imaging and therapy
11/22/2006	CN1285582C Thioflavin derivatives for alzheimer's disease premortal diagnosis and starch-like protein in vivo image forming and precaution
11/21/2006	US7138497 Genetic engineering; crosslinking polypeptide on carrier
11/21/2006	US7138390 3 alpha ,7 alpha -dihydroxy-6 alpha -ethyl-5 beta -cholan-24-oic acid and salts, solvates or amino acid conjugates thereof; treatment of a farnesoid X receptor mediated disease such as hypercholesteremia, hyperlipidemia, low HDL-cholesterol, and high triglycerides
11/21/2006	US7138104 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
11/21/2006	US7138103 Completitive binding
11/16/2006	WO2006122237A2 Imaging of neural and organ injury or damage
11/16/2006	WO2006121447A2 Therapeutic assembly
11/16/2006	WO2006121035A1 Process for producing organic compound labeled with radioactive halogen
11/16/2006	US20060258841 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/16/2006	US20060258566 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use
11/16/2006	US20060257842 Cryopreservation media and molecules
11/16/2006	US20060257398 humanized, chimeric and human anti-CD19 antibodies, anti-CD19 antibody fusion proteins, and fragments thereof that bind to a human B cell marker; B-cell malignancies and autoimmune diseases
11/16/2006	US20060257318 Method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
11/16/2006	US20060257317 Combination therapy in the treatment of cancer
11/16/2006	US20060257316 Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level
11/16/2006	US20060257315 Activation and production of radiolabeled particles
11/16/2006	CA2608058A1 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
11/16/2006	CA2607281A1 Anti-cd19 antibody therapy for autoimmune disease
11/15/2006	EP1720996A1 Fusion proteins containing recombinant cytotoxic rnases
11/15/2006	EP1720580A2 Improvement in the ligand protection for mercaptoacetyl triglycine
11/15/2006	EP1720575A2 Therapeutic and diagnostic conjugates for use with multispecific antibodies
11/15/2006	EP1720521A2 Improved efficacy and safety of targeted particulate agents with decoy systems
11/15/2006	EP1412383B1 Peptide conjugates, their derivatives with metal complexes and use thereof for magnetic resonance imaging (mri)
11/15/2006	EP1347711B1 Apparatus for therapeutic emr treatment of the skin
11/15/2006	EP1206493B1 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus
11/15/2006	CN1863866A Finely particulate composite containing carbon compound encapsulated therein
11/15/2006	CN1861616A Compound for tumour display and caring and preparation process thereof
11/15/2006	CN1861201A Medical implant of sodium iodide and its prepn. method
11/14/2006	US7135496 Antitumor, anticancer agents; rheumatic diseases; autoimmune diseases
11/14/2006	US7135296 Detecting and measurement of transition elements in a sample; obtain labeled bioploymer, incubate with complex, separating bound tagged biopolymer, measure amount of bound biopolymer
11/14/2006	US7135162 Agent for diagnosing and treating malignant tumors
11/09/2006	WO2006119438A2 Methods for measuring cholesterol metabolism and transport
11/09/2006	WO2006116798A1 A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
11/09/2006	US20060251668 Tumor-specific recognition molecules
11/09/2006	US20060251580 Lectin conjugates
11/09/2006	US20060251579 Medicament for the two-step perioperative therapy of solid tumours
11/09/2006	US20060251578 Therapeutic and diagnostic compounds, compositions, and methods
11/09/2006	US20060251577 Orally administering a positive contrast agent comprising meglumine diatrizoate, sodium diatrizoate; simethicone; famotidine; and aspartame; applying computerized axial tomography to the patient approximately 50 minutes afterwards; side effect reduction, bulk storage, bioavailability
11/09/2006	US20060251576 Methods for measuring cholesterol metabolism and transport
11/09/2006	US20060251575 Method for preventing nasolacrimal duct obstruction
11/09/2006	US20060251574 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
11/09/2006	CA2606447A1 Methods for measuring cholesterol metabolism and transport
11/09/2006	CA2605763A1 A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
11/08/2006	EP1719754A1 DTPA derivatives and metal complexes therof, and radiation source and contrast agent including the metal complexes
11/08/2006	EP1719529A1 Contrast medium for thrombus formation
11/08/2006	EP1718749A1 Humanized antibody
11/08/2006	EP1718737A1 Cancerous disease modifying antibodies
11/08/2006	EP1718736A1 Cancerous disease modifying antibodies
11/08/2006	EP1718656A2 Crowned dithiocarbamate metal complexes and methods for their use
11/08/2006	EP1718342A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
11/08/2006	CN1283647C Technetium-99m marked isonitrile group mating material, preparing process and uses thereof
11/07/2006	US7132513 Bifunctional chelating agent
11/07/2006	US7132400 Exposing the cancer cell to a peptide has antiestrotrophic activity and is eight to twenty amino acids long; use of tamoxifen therapy in combination with the peptide therapy
11/07/2006	US7132295 Isotopically coded affinity markers 3
11/02/2006	WO2006116629A2 The preparation of molecular imaging probes using click chemistry
11/02/2006	WO2006115416A2 Liposomes
11/02/2006	WO2006114474A2 Saline solution comprising [13n] nh4+ and a device
11/02/2006	WO2006114336A1 Fluorinated 3'-deoxythymidine derivatives, a method for their preparation and their use
11/02/2006	WO2006114324A1 Compounds comprising cyclized somatostatin receptor binding peptides
11/02/2006	WO2006072948A3 Gastro-retentive diagnostic assemblies
11/02/2006	WO2006070290A3 Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders
11/02/2006	WO2006044716A3 CELL PERMEABLE NANOCONJUGATES OF SHELL-CROSSLINKED KNEDEL (SCK) AND PEPTIDE NUCLEIC ACIDS ('PNAs') WITH UNIQUELY EXPRESSED OR OVER-EXPRESSED mRNA TARGETING SEQUENCES FOR EARLY DIAGNOSIS AND THERAPY OF CANCER
11/02/2006	US20060247270 3-Substituted-2(Arylalkyl)-1-Azabicycloalkanes and Methods of Use Thereof
11/02/2006	US20060246126 Therapeutic liposome composition and method of preparation
11/02/2006	US20060246085 Methods for manipulating satiety
11/02/2006	US20060246077 Use of antibodies against the MUC18 antigen
11/02/2006	US20060246005 Poly(peptide) as a chelator: methods of manufacture and uses
11/02/2006	US20060246004 Antibody variants and uses thereof
11/02/2006	US20060246003 Donepezil, memantine; ethylcellulose high molecular weight basic water-insoluble polymer; methacrylic acid-ethyl acrylate high molecular weight acidic enteric polymer; sustained-release, time release
11/02/2006	EP1717247A1 Cyclic peptides binding to the somatostatin receptor
11/02/2006	EP1716871A2 Diagnostic imaging contrast agents with extended blood retention
11/02/2006	EP1651957A4 Fluorescent magnetic nanoparticles and process of preparation
11/02/2006	CA2607455A1 Antibodies with immune effector activity and that internalize in endosialin-positive cells
11/02/2006	CA2607444A1 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
11/02/2006	CA2606094A1 The preparation of molecular imaging probes using click chemistry
11/01/2006	CN1856329A Inherently radiopaque polymeric products for embolotherapy
11/01/2006	CN1853732A Matrix metalloproteinase inhibitors as target component in diagnose agent
10/2006
10/31/2006	US7129327 Polypeptide and protein derivatives and process for their preparation
10/31/2006	US7128912 Fibronectin binding protein compositions and methods of use
10/31/2006	US7128895 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability
10/31/2006	US7128893 Used to target radionuclides to cells, such as a variety of tumor cell types, for use in diagnostic imaging; peptide derivatives of vitamins such as folate, riboflavin, thiamine, vitamin B12, and biotin chelated to a radionuclide
10/26/2006	WO2006113724A1 Method and apparatus for kidney function analysis

1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 243